區塊鏈股雄岸科技午後大幅拉昇20% A股區塊鏈尾盤異動
格隆匯11月5日丨區塊鏈概念股雄岸科技(1647.HK)午後拉昇明顯,一度大漲超28%。現漲20%,報0.54%,暫成交1877萬港元,最新總市值5.57億港元。桐成控股(1611.HK)漲超5%跟漲,元徵科技、卓爾智聯未有表現。

同時A股區塊鏈尾盤呈異動拉昇。雄岸科技佈局業務範圍涉及區塊鏈相關項目投資、交易平台設立、技術研發等。目前,區塊鏈在中國與新加坡均已進入行業快速成長、引起政府關注及積極參與的階段。
天風證券研報稱,公司工業大麻全產業鏈佈局,積極開展區塊鏈合作,給予“強大於市”評級。分析人士稱,從長線投資的角度看,區塊鏈值得跟蹤,投資者關注的重點可以放在與區塊鏈公司有合作性質的上市公司上。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.